Financial Outcomes of Managed Entry Agreements for Pharmaceuticals in Italy

This observational study analyzes whether managed entry agreements lower pharmaceutical expenditures using individually collected data from 2019 to 2021 in Italy.

from JAMA Health Forum New Online https://ift.tt/GBNAnja

Comments

Popular posts from this blog